These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 25748122)

  • 21. Synthesis and biological evaluation of new BSH-conjugated chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer.
    Asano R; Nagami A; Fukumoto Y; Miura K; Yazama F; Ito H; Sakata I; Tai A
    J Photochem Photobiol B; 2014 Nov; 140():140-9. PubMed ID: 25123528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of the subcellular distribution of mercaptoundecahydro-closo-dodecaborate (BSH) in human glioblastoma multiforme by electron microscopy.
    Neumann M; Kunz U; Lehmann H; Gabel D
    J Neurooncol; 2002 Apr; 57(2):97-104. PubMed ID: 12125978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Closo-dodecaborate(2-) as a linker for iodination of macromolecules. Aspects on conjugation chemistry and biodistribution.
    Tolmachev V; Koziorowski J; Sivaev I; Lundqvist H; Carlsson J; Orlova A; Gedda L; Olsson P; Sjöberg S; Sundin A
    Bioconjug Chem; 1999; 10(3):338-45. PubMed ID: 10346862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of electroporation on cell killing by boron neutron capture therapy using borocaptate sodium (10B-BSH).
    Ono K; Kinashi Y; Masunaga S; Suzuki M; Takagaki M
    Jpn J Cancer Res; 1998 Dec; 89(12):1352-7. PubMed ID: 10081497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A periodic development of BPA and BSH based derivatives in boron neutron capture therapy (BNCT).
    Lamba M; Goswami A; Bandyopadhyay A
    Chem Commun (Camb); 2021 Jan; 57(7):827-839. PubMed ID: 33399147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Boron-enriched streptavidin potentially useful as a component of boron carriers for neutron capture therapy of cancer.
    Sano T
    Bioconjug Chem; 1999; 10(5):905-11. PubMed ID: 10502360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of mercaptoundecahydrododecaborate (BSH) with phosphatidylcholine: relevance to boron neutron capture therapy.
    Kageji T; Otersen B; Gabel D; Huiskamp R; Nakagawa Y; Matsumoto K
    Biochim Biophys Acta; 1998 Apr; 1391(3):377-83. PubMed ID: 9555099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maleimide-functionalized closo-dodecaborate albumin conjugates (MID-AC): Unique ligation at cysteine and lysine residues enables efficient boron delivery to tumor for neutron capture therapy.
    Kikuchi S; Kanoh D; Sato S; Sakurai Y; Suzuki M; Nakamura H
    J Control Release; 2016 Sep; 237():160-7. PubMed ID: 27422608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxoundecahydro-closo-dodecaborate(2-) as a Nucleophile. Preparation and Structural Characterization of O-Alkyl and O-Acyl Derivatives of Hydroxoundecahydro-closo-dodecaborate(2-).
    Peymann T; Lork E; Gabel D
    Inorg Chem; 1996 Feb; 35(5):1355-1360. PubMed ID: 11666332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined use of sodium borocaptate and buthionine sulfoximine in boron neutron capture therapy enhanced tissue boron uptake and delayed tumor growth in a rat subcutaneous tumor model.
    Yoshida F; Yamamoto T; Nakai K; Kumada H; Shibata Y; Tsuruta W; Endo K; Tsurubuchi T; Matsumura A
    Cancer Lett; 2008 May; 263(2):253-8. PubMed ID: 18272285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of sulfhydrylborane-dextran conjugates for boron neutron capture therapy.
    Holmberg A; Meurling L
    Bioconjug Chem; 1993; 4(6):570-3. PubMed ID: 8305528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model.
    Iguchi Y; Michiue H; Kitamatsu M; Hayashi Y; Takenaka F; Nishiki T; Matsui H
    Biomaterials; 2015 Jul; 56():10-7. PubMed ID: 25934274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectromicroscopy of boron in human glioblastomas following administration of Na2B12H11SH.
    Gilbert B; Perfetti L; Fauchoux O; Redondo J; Baudat PA; Andres R; Neumann M; Steen S; Gabel D; Mercanti D; Ciotti MT; Perfetti P; Margaritondo G; De Stasio G
    Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics; 2000 Jul; 62(1 Pt B):1110-8. PubMed ID: 11088567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, liposomal preparation, and in vitro toxicity of two novel dodecaborate cluster lipids for boron neutron capture therapy.
    Justus E; Awad D; Hohnholt M; Schaffran T; Edwards K; Karlsson G; Damian L; Gabel D
    Bioconjug Chem; 2007; 18(4):1287-93. PubMed ID: 17569498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of 10B antitumoral compounds by means of flow-injection into ESI-MS/MS.
    Basilico F; Sauerwein W; Pozzi F; Wittig A; Moss R; Mauri PL
    J Mass Spectrom; 2005 Dec; 40(12):1546-9. PubMed ID: 16320299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Boron neutron capture therapy of brain tumors: investigation of urinary metabolites and oxidation products of sodium borocaptate by electrospray ionization mass spectrometry.
    Gibson CR; Staubus AE; Barth RF; Yang W; Kleinholz NM; Jones RB; Green-Church K; Tjarks W; Soloway AH
    Drug Metab Dispos; 2001 Dec; 29(12):1588-98. PubMed ID: 11717178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
    Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homocystamide Conjugates of Human Serum Albumin as a Platform to Prepare Bimodal Multidrug Delivery Systems for Boron Neutron Capture Therapy.
    Popova T; Dymova MA; Koroleva LS; Zakharova OD; Lisitskiy VA; Raskolupova VI; Sycheva T; Taskaev S; Silnikov VN; Godovikova TS
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy.
    Ueno M; Ban HS; Nakai K; Inomata R; Kaneda Y; Matsumura A; Nakamura H
    Bioorg Med Chem; 2010 May; 18(9):3059-65. PubMed ID: 20371186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.